Science Explorer Interactive view Map
Company · Leeds · United Kingdom

4D Pharma (United Kingdom)

Research works
28
▲ 4% vs 2013–17
Citations
436
15.8 per fractional work
Top-10% rate
16.2%
record average 16.5%
Open access
36%
world 28%

Not ranked overall: 4D Pharma (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.20× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.18× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.10× its world share, 0 worksImmunology and Micro…Neuroscience: 4.78× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.15× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.46× its world share, 0 worksComputer ScienceEngineering: 0.15× its world share, 0 worksEngineeringMaterials Science: 0.54× its world share, 0 worksMaterials ScienceHealth Professions: 0.36× its world share, 0 worksHealth ProfessionsMedicine: 2.97× its world share, 3 worksMedicineDecision Sciences: 1.38× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.55× its world share, 0 worksEconomics, Econometr…Psychology: 0.55× its world share, 0 worksPsychologyworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Neuroscience, 4.8×. Every wedge is a field page.

Which keywords describe research at 4D Pharma (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Gene Expression, Signal Transduction, Cancer, Metabolic Regulation, Genomics, Yeast and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 39 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 39 words, with their numbers
  1. Inflammation4▲ 5.5×9 topics
  2. Gene Expression3▲ 18×4 topics
  3. Cancer2▲ 6.5×7 topics
  4. Oxidative Stress2▲ 4.5×7 topics
  5. Signal Transduction2▲ 35×3 topics
  6. Metabolic Regulation2▲ 27×2 topics
  7. Genomics2▲ 21×1 topic
  8. Yeast2▲ 172×1 topic
  9. Immunotherapy2▲ 11×5 topics
  10. Epidemiology2▲ 1.53×10 topics
  11. Microbial Communities2▲ 17×2 topics
  12. Chemotherapy1▲ 7.0×5 topics
  13. Gut Microbiota1▲ 15×2 topics
  14. Metabolism1▲ 7.7×5 topics
  15. Metagenomic Analysis1▲ 87×1 topic
  16. Short-Chain Fatty Acids1▲ 87×1 topic
  17. Tumor Microenvironment1▲ 14×3 topics
  18. Blood-Brain Barrier1▲ 74×1 topic
  19. Neurovascular Unit1▲ 344×1 topic
  20. Pattern Recognition Receptors1▲ 33×2 topics
  21. Antioxidant1▲ 6.5×3 topics
  22. Genetic Variation1▲ 14×2 topics
  23. Genome-Wide Association1▲ 52×2 topics
  24. Tumor Targeting1▲ 32×2 topics
  25. Alzheimer's Disease1▲ 14×2 topics
  26. Anti-inflammatory1▲ 14×2 topics
  27. Arginine Deprivation1▲ 91×1 topic
  28. Bacterial Therapy1▲ 91×1 topic
  29. Chaperones1▲ 61×2 topics
  30. Clinical Trials1▲ 6.6×6 topics
  31. Marker-Assisted Selection1▲ 42×2 topics
  32. Neuroprotective1▲ 33×2 topics
  33. Innate Antiviral Responses1▲ 52×1 topic
  34. Keap1-Nrf2-ARE Pathway1▲ 145×1 topic
  35. Mitochondrial Dysfunction1▲ 9.9×3 topics
  36. Nobiletin1▲ 1091×1 topic
  37. Nrf21▲ 145×1 topic
  38. Tangeretin1▲ 1091×1 topic
  39. Toll-like Receptors1▲ 21×1 topic

Which research topics does 4D Pharma (United Kingdom) publish most on?

By volume in 2022–2025: Gut microbiota and health, Inhalation and Respiratory Drug Delivery, Asthma and respiratory diseases and Cancer Mechanisms and Therapy.

  1. 1 Gut microbiota and health Molecular Biology 0 works
  2. 2 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
  3. 3 Asthma and respiratory diseases Physiology 0 works
  4. 4 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 0 works
  5. 5 Biomedical Ethics and Regulation Physiology 0 works
  6. 6 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  7. 7 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
  8. 8 Cancer Immunotherapy and Biomarkers Oncology 0 works
  9. 9 Cancer Research and Treatments Biotechnology 0 works
  10. 10 Bladder and Urothelial Cancer Treatments Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.5%not open64.5%

World: 28% of research is openly available.

with international co-authors26.7%domestic only73.3%

World: 19% is written across borders.

How has 4D Pharma (United Kingdom)'s research output changed?

Output in 2018–2022 was 4% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Leeds

All research institutions in Leeds

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.